Provided by Tiger Trade Technology Pte. Ltd.

Eton Pharmaceuticals, Inc.

51.49
-7.7000-13.01%
Post-market: 51.500.0100+0.02%18:29 EDT
Volume:1.81M
Turnover:94.51M
Market Cap:1.47B
PE:132.03
High:59.66
Open:59.61
Low:48.79
Close:59.19
52wk High:66.37
52wk Low:14.27
Shares:28.58M
Float Shares:22.30M
Volume Ratio:3.26
T/O Rate:8.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3900
EPS(LYR):-0.1710
ROE:35.97%
ROA:11.86%
PB:31.59
PE(LYR):-301.13

Loading ...

Eton Pharmaceuticals Down over 15%, on Pace for Largest Percent Decrease Since November 2023

Dow Jones
·
3 hours ago

Eton Pharmaceuticals Launches Impavido Capsules to Treat Leishmaniasis

MT Newswires Live
·
Sep 28

Eton Pharmaceuticals - Holds Exclusive Commercialization Rights for Impavido in the U.S.

THOMSON REUTERS
·
Sep 28

Eton Pharmaceuticals Announces U.S. Commercial Availability of Impavido® (Miltefosine) Capsules

THOMSON REUTERS
·
Sep 28

Eton Pharma Director Paul V. Maier Reports Disposal of Common Shares Worth $2.94 Million

Reuters
·
Aug 29

Eton Pharmaceuticals Hosts One-on-One Investor Meetings at Wells Fargo Healthcare Conference

Reuters
·
Aug 27

Eton Pharmaceuticals (ETON) Stock May Be Fully Valued Following Raised Guidance

Simply Wall St.
·
Aug 27

Eton Pharma Chief Business Officer David Krempa Reports Disposal of 25,000 Common Shares Valued at $1.63 Million

Reuters
·
Aug 25

Eton Pharmaceuticals (ETON) Returns To Profit As Valuation Debate Gets Harder To Ignore

Simply Wall St.
·
Aug 24

Eton Pharma President and CEO Sean Brynjelsen Sells USD 6.19 Million in Common Shares

Reuters
·
Aug 21

Dow Falls Over 100 Points, Records Weekly Loss: Investor Sentiment Weakens, but Fear Index Remains in ‘Greed’ Zone

Benzinga Earnings
·
Aug 17

Eton Pharmaceuticals price target raised to $70 from $40 at B. Riley

TIPRANKS
·
Aug 16

Emmaus Life Sciences Q2 Revenue Soars on Licensing Deal

Reuters
·
Aug 15

Eton Pharmaceuticals is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Aug 15

Top Midday Gainers

MT Newswires Live
·
Aug 15

Scienture Q2 Revenue Surges on Rezenopy Launch

Reuters
·
Aug 14

B. Riley Adjusts Price Target on Eton Pharmaceuticals to $70 From $40, Maintains Buy Rating

MT Newswires Live
·
Aug 14

U.S. Stocks on the MOVE-Reddit, Capricor Therapeutics, Birkenstock

Reuters
·
Aug 14

Eton Pharmaceuticals Shares Rise 24.3% Premarket After Q2 Profit Beat

THOMSON REUTERS
·
Aug 14

Eton Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $70 from $65

THOMSON REUTERS
·
Aug 14